Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With Human Immunodeficiency Virus (HILLCLIMBER)

NCT02841774 is registered in ClinicalTrials.gov with Matthew Feinstein as lead sponsor.

NCT NCT02841774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02841774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With Human Immunodeficiency Virus (HILLCLIMBER)
Lead sponsor
Matthew Feinstein
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2016
Completion date
June 30, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, hiv infection